A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan

A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quanti...

Full description

Saved in:
Bibliographic Details
Published inYAKUGAKU ZASSHI Vol. 137; no. 7; pp. 903 - 908
Main Authors Hirayama, Fumitoshi, Iohara, Daisuke, Otagiri, Masaki, Anraku, Makoto, Zingami, Sachiko, Maruyama, Toru, Shimoishi, Kazuki, Uto, Ayako, Kadowaki, Daisuke
Format Journal Article
LanguageEnglish
Japanese
Published Japan The Pharmaceutical Society of Japan 01.07.2017
Pharmaceutical Society of Japan
Subjects
Online AccessGet full text
ISSN0031-6903
1347-5231
1347-5231
DOI10.1248/yakushi.17-00006

Cover

Abstract A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community.
AbstractList A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community.
A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community. A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community.
Author Kadowaki, Daisuke
Zingami, Sachiko
Iohara, Daisuke
Hirayama, Fumitoshi
Uto, Ayako
Maruyama, Toru
Shimoishi, Kazuki
Otagiri, Masaki
Anraku, Makoto
Author_xml – sequence: 1
  fullname: Hirayama, Fumitoshi
  organization: Faculty of Pharmaceutical Sciences, Sojo University
– sequence: 1
  fullname: Iohara, Daisuke
  organization: Faculty of Pharmaceutical Sciences, Sojo University
– sequence: 1
  fullname: Otagiri, Masaki
  organization: Faculty of Pharmaceutical Sciences, Sojo University
– sequence: 1
  fullname: Anraku, Makoto
  organization: Faculty of Pharmaceutical Sciences, Sojo University
– sequence: 1
  fullname: Zingami, Sachiko
  organization: Department of Pharmacy, Japanese Red Cross Kumamoto Hospital
– sequence: 1
  fullname: Maruyama, Toru
  organization: Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University
– sequence: 1
  fullname: Shimoishi, Kazuki
  organization: Department of Pharmacy, Japanese Red Cross Kumamoto Hospital
– sequence: 1
  fullname: Uto, Ayako
  organization: Minori Dispensing Pharmacy
– sequence: 1
  fullname: Kadowaki, Daisuke
  organization: Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28674306$$D View this record in MEDLINE/PubMed
BookMark eNqNkkFv1DAQhS1URJfSOyeUI5cUT-zYzrFaQRdUxB7gbDlep3FJ7GAnqvbf4yTbReKA8GHG0rxvZvTs1-jCeWcQegv4BgoqPhzVzym29gZ4jtNhL9AGCOV5WRC4QBuMCeSswuQSXcdoa4yLdEoQr9BlIRinBLMNMrfZ1veDCjZ6l_kmG1uT7Vsfh9aHKaaiG40bM-uyfTBRBzuMNim_moPVar7GrPEh25neH6zqjtHGbJ8KCYoz9UUNyr1BLxvVRXN9ylfox6eP37e7_P7b3eft7X2uOdAxh4YxqjhWpKlqrHBREahJqWtKVWlIRRgWlYBKMEGgrFhBFYVScApJS0VJrhCsfSc3qOOT6jo5BNurcJSA5eyaPLkmgcvFtcS8X5kh-F-TiaPsbdSm65QzfooSqjRCACzSdyfpVPfmcO79bGcSsFWgg48xmEZqOy4ujUHZ7l9L4L_A_9j7bkX65Sk67zrrjHz0U3DJY6kjn5kHWeCZAcLxnCqJ05-YgygqXLISUqfd2ukxjurBnEerMFrdmT-jCZd8ic9LnCW6VUEaR34DFdXL0g
CitedBy_id crossref_primary_10_1038_s41387_019_0080_2
crossref_primary_10_1053_j_jrn_2020_02_003
crossref_primary_10_5649_jjphcs_44_55
Cites_doi 10.1093/ndt/13.8.2037
10.2215/CJN.07640711
10.2215/CJN.09250912
10.1038/sj.ki.5001514
10.1038/ki.2013.147
10.1111/j.0894-0959.2004.17308.x
10.1681/ASN.V12102131
10.2215/CJN.00810110
10.1111/j.1525-139X.2011.00849.x
10.1111/sdi.12042
10.1093/ndt/gft280
10.1111/j.1525-139X.2007.00204.x
10.1053/j.ajkd.2014.01.429
10.1056/NEJMoa0706130
10.1111/sdi.12159
10.1681/ASN.2008020159
10.1053/ajkd.1998.v31.pm9531176
10.1038/ki.2015.67
ContentType Journal Article
Copyright 2017 The Pharmaceutical Society of Japan
Copyright_xml – notice: 2017 The Pharmaceutical Society of Japan
CorporateAuthor cDepartment of Biopharmaceutics
bFaculty of Pharmaceutical Sciences
Graduate School of Pharmaceutical Sciences
Japanese Red Cross Kumamoto Hospital
Sojo University
aDepartment of Pharmacy
dMinori Dispensing Pharmacy
Kumamoto University
CorporateAuthor_xml – name: aDepartment of Pharmacy
– name: bFaculty of Pharmaceutical Sciences
– name: Kumamoto University
– name: Graduate School of Pharmaceutical Sciences
– name: cDepartment of Biopharmaceutics
– name: Sojo University
– name: Japanese Red Cross Kumamoto Hospital
– name: dMinori Dispensing Pharmacy
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1248/yakushi.17-00006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5231
EndPage 908
ExternalDocumentID 10.1248/yakushi.17-00006
28674306
10_1248_yakushi_17_00006
cs7yakug_2017_013707_019_0903_09082905651
article_yakushi_137_7_137_17_00006_article_char_en
Genre Journal Article
Comparative Study
GroupedDBID .55
123
29R
2WC
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
E3Z
EBS
EJD
F5P
GX1
HH5
JMI
JSF
JSH
MOJWN
OVT
P2P
RJT
RNS
RZJ
X7M
XSB
AAYXX
CITATION
53G
AFFNX
CGR
CUY
CVF
ECM
EIF
KQ8
LPU
NPM
X7J
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c714t-1f664a70a3f9b0a02931b35cb44a5e39360898198683159624a4158741a024853
IEDL.DBID UNPAY
ISSN 0031-6903
1347-5231
IngestDate Wed Oct 01 16:01:50 EDT 2025
Fri Jul 11 09:04:15 EDT 2025
Thu Jan 02 22:22:11 EST 2025
Tue Jul 01 03:47:42 EDT 2025
Thu Apr 24 23:05:27 EDT 2025
Thu Jul 10 16:10:25 EDT 2025
Wed Sep 03 06:27:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords hemodialysis
branded
prescribed medication
generic
phosphorus
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c714t-1f664a70a3f9b0a02931b35cb44a5e39360898198683159624a4158741a024853
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_pdf
PMID 28674306
PQID 1915881106
PQPubID 23479
PageCount 6
ParticipantIDs unpaywall_primary_10_1248_yakushi_17_00006
proquest_miscellaneous_1915881106
pubmed_primary_28674306
crossref_citationtrail_10_1248_yakushi_17_00006
crossref_primary_10_1248_yakushi_17_00006
medicalonline_journals_cs7yakug_2017_013707_019_0903_09082905651
jstage_primary_article_yakushi_137_7_137_17_00006_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-07-01
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle YAKUGAKU ZASSHI
PublicationTitleAlternate YAKUGAKU ZASSHI
PublicationYear 2017
Publisher The Pharmaceutical Society of Japan
Pharmaceutical Society of Japan
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Pharmaceutical Society of Japan
References 8) Fouque D., Horne R., Cozzolino M., Kalantar-Zadeh K., Am. J. Kidney Dis., 64, 143-150 (2014).
14) Di Iorio B., Di Micco L., Torraca S., Sirico M. L., Russo L., Pota A., Mirenghi F., Russo D., Clin. J. Am. Soc. Nephrol., 7, 581-587 (2012).
15) Isakova T., Barchi-Chung A., Enfield G., Smith K., Vargas G., Houston J., Xie H., Wahl P., Schiavenato E., Dosch A., Gutiérrez O. M., Diego J., Lenz O., Contreras G., Mendez A., Weiner R. B., Wolf M., Clin. J. Am. Soc. Nephrol., 8, 1009-1018 (2013).
16) Daugirdas J. T., Finn W. F., Emmett M., Chertow G. M., Semin. Dial., 24, 41-49 (2011).
10) Sherman R. A., Ravella S., Kapoian T., Kidney Int., 87, 1097-1099 (2015).
18) Clark S., Farrington K., Chilcot J., Semin. Dial., 27, 42-49 (2014).
5) Ribeiro S., Ramos A., Brandão A., Rebelo J. R., Guerra A., Resina C., Vila-Lobos A., Carvalho F., Remédio F., Ribeiro F., Nephrol. Dial. Transplant., 13, 2037-2040 (1998).
13) Ikizler T. A., Cano N. J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M. K., Stenvinkel P., TerWee P., Teta D., Wang A. Y. M., Wanner C., Kidney Int., 84, 1096-1107 (2013).
2) Block G. A., Hulbert-Shearon T. E., Levin N. W., Port F. K., Am. J. Kidney Dis., 31, 607-617 (1998).
1) Gutiérrez O. M., Mannstadt M., Isakova T., Rauh-Hain J. A., Tamez H., Shan A., Smith K., Lee H., Thadhani R., Jüppner H., Wolf M., N. Engl. J. Med., 359, 584-592 (2008).
9) Sherman R. A., Semin Dial., 20, 16-18 (2007).
7) Calvo M. S., Uribarri J., Semin. Dial., 26, 54-61 (2013).
3) Ganesh S. K., Stack A. G., Levin N. W., Hulbert-Shearon T., Port F. K., J. Am. Soc. Nephrol., 12, 2131-2138 (2001).
4) Kalantar-Zadeh K., Kuwae N., Regidor D. L., Kovesdy C. P., Kilpatrick R. D., Shinaberger C. S., McAllister C. J., Budoff M. J., Salusky I. B., Kopple J. D., Kidney Int., 70, 771-780 (2006).
6) Goodman W. G., Semin. Dial., 17, 209-216 (2004).
12) Eddington H., Hoefield R., Sinha S., Chrysochou C., Lane B., Foley R. N., Hegarty J., New J., O'Donoghue D. J., Middleton R. J., Kalra P. A., Clin. J. Am. Soc. Nephrol., 5, 2251-2257 (2010).
17) Wang S., Alfieri T., Ramakrishnan K., Braunhofer P., Newsome B. A., Nephrol. Dial. Transplant., 29, 2092-2099 (2014).
11) Moranne O., Froissart M., Rossert J., Gauci C., Boffa J. J., Haymann J. P., M'rad M. B., Jacquot C., Houillier P., Stengel B., Fouqueray B., NephroTest Study Group, J. Am. Soc. Nephrol., 20, 164-171 (2009).
11
12
13
14
15
16
17
18
1
2
3
4
5
6
7
8
9
10
References_xml – reference: 1) Gutiérrez O. M., Mannstadt M., Isakova T., Rauh-Hain J. A., Tamez H., Shan A., Smith K., Lee H., Thadhani R., Jüppner H., Wolf M., N. Engl. J. Med., 359, 584-592 (2008).
– reference: 3) Ganesh S. K., Stack A. G., Levin N. W., Hulbert-Shearon T., Port F. K., J. Am. Soc. Nephrol., 12, 2131-2138 (2001).
– reference: 12) Eddington H., Hoefield R., Sinha S., Chrysochou C., Lane B., Foley R. N., Hegarty J., New J., O'Donoghue D. J., Middleton R. J., Kalra P. A., Clin. J. Am. Soc. Nephrol., 5, 2251-2257 (2010).
– reference: 9) Sherman R. A., Semin Dial., 20, 16-18 (2007).
– reference: 16) Daugirdas J. T., Finn W. F., Emmett M., Chertow G. M., Semin. Dial., 24, 41-49 (2011).
– reference: 8) Fouque D., Horne R., Cozzolino M., Kalantar-Zadeh K., Am. J. Kidney Dis., 64, 143-150 (2014).
– reference: 13) Ikizler T. A., Cano N. J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M. K., Stenvinkel P., TerWee P., Teta D., Wang A. Y. M., Wanner C., Kidney Int., 84, 1096-1107 (2013).
– reference: 7) Calvo M. S., Uribarri J., Semin. Dial., 26, 54-61 (2013).
– reference: 11) Moranne O., Froissart M., Rossert J., Gauci C., Boffa J. J., Haymann J. P., M'rad M. B., Jacquot C., Houillier P., Stengel B., Fouqueray B., NephroTest Study Group, J. Am. Soc. Nephrol., 20, 164-171 (2009).
– reference: 2) Block G. A., Hulbert-Shearon T. E., Levin N. W., Port F. K., Am. J. Kidney Dis., 31, 607-617 (1998).
– reference: 4) Kalantar-Zadeh K., Kuwae N., Regidor D. L., Kovesdy C. P., Kilpatrick R. D., Shinaberger C. S., McAllister C. J., Budoff M. J., Salusky I. B., Kopple J. D., Kidney Int., 70, 771-780 (2006).
– reference: 18) Clark S., Farrington K., Chilcot J., Semin. Dial., 27, 42-49 (2014).
– reference: 5) Ribeiro S., Ramos A., Brandão A., Rebelo J. R., Guerra A., Resina C., Vila-Lobos A., Carvalho F., Remédio F., Ribeiro F., Nephrol. Dial. Transplant., 13, 2037-2040 (1998).
– reference: 14) Di Iorio B., Di Micco L., Torraca S., Sirico M. L., Russo L., Pota A., Mirenghi F., Russo D., Clin. J. Am. Soc. Nephrol., 7, 581-587 (2012).
– reference: 6) Goodman W. G., Semin. Dial., 17, 209-216 (2004).
– reference: 17) Wang S., Alfieri T., Ramakrishnan K., Braunhofer P., Newsome B. A., Nephrol. Dial. Transplant., 29, 2092-2099 (2014).
– reference: 10) Sherman R. A., Ravella S., Kapoian T., Kidney Int., 87, 1097-1099 (2015).
– reference: 15) Isakova T., Barchi-Chung A., Enfield G., Smith K., Vargas G., Houston J., Xie H., Wahl P., Schiavenato E., Dosch A., Gutiérrez O. M., Diego J., Lenz O., Contreras G., Mendez A., Weiner R. B., Wolf M., Clin. J. Am. Soc. Nephrol., 8, 1009-1018 (2013).
– ident: 5
  doi: 10.1093/ndt/13.8.2037
– ident: 14
  doi: 10.2215/CJN.07640711
– ident: 15
  doi: 10.2215/CJN.09250912
– ident: 4
  doi: 10.1038/sj.ki.5001514
– ident: 13
  doi: 10.1038/ki.2013.147
– ident: 6
  doi: 10.1111/j.0894-0959.2004.17308.x
– ident: 3
  doi: 10.1681/ASN.V12102131
– ident: 12
  doi: 10.2215/CJN.00810110
– ident: 16
  doi: 10.1111/j.1525-139X.2011.00849.x
– ident: 7
  doi: 10.1111/sdi.12042
– ident: 17
  doi: 10.1093/ndt/gft280
– ident: 9
  doi: 10.1111/j.1525-139X.2007.00204.x
– ident: 8
  doi: 10.1053/j.ajkd.2014.01.429
– ident: 1
  doi: 10.1056/NEJMoa0706130
– ident: 18
  doi: 10.1111/sdi.12159
– ident: 11
  doi: 10.1681/ASN.2008020159
– ident: 2
  doi: 10.1053/ajkd.1998.v31.pm9531176
– ident: 10
  doi: 10.1038/ki.2015.67
SSID ssib002222518
ssib002484306
ssib001136365
ssib002223935
ssib002484304
ssib002484305
ssib000959844
ssib002822080
ssib003105265
ssib023161479
ssj0023355
ssib000576198
ssib002499502
ssib003105266
ssib000937675
ssib000972830
ssib001536036
ssib002222551
ssib058494605
ssib058494604
Score 2.1051626
Snippet A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a...
SourceID unpaywall
proquest
pubmed
crossref
medicalonline
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 903
SubjectTerms Amlodipine - chemistry
branded
Drugs, Generic - chemistry
generic
hemodialysis
Humans
Japan
Paroxetine - chemistry
phosphorus
Phosphorus - adverse effects
Phosphorus - analysis
Phosphorus, Dietary - adverse effects
Phosphorus, Dietary - analysis
prescribed medication
Prescription Drugs - chemistry
Renal Dialysis
Title A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan
URI https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_article/-char/en
http://mol.medicalonline.jp/library/journal/download?GoodsID=cs7yakug/2017/013707/019&name=0903-0908e
https://www.ncbi.nlm.nih.gov/pubmed/28674306
https://www.proquest.com/docview/1915881106
https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_pdf
UnpaywallVersion publishedVersion
Volume 137
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX YAKUGAKU ZASSHI, 2017/07/01, Vol.137(7), pp.903-908
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1347-5231
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023355
  issn: 0031-6903
  databaseCode: HH5
  dateStart: 18810101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1347-5231
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023355
  issn: 0031-6903
  databaseCode: DIK
  dateStart: 19470101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1347-5231
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023355
  issn: 0031-6903
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NDgkmxPdG-ZiMhCYxLW1SO19vVIOpDDH1YZXGk-UkTsfWJdWSCJW_nrs4SRlCIMRL8pC7kz_O559j388AbwKbptE0sGw34ZbgSWIpRygrVZT16KY-9yjB-fOJN5mJ4zP3bAPet7kwdKzyAnHRXNNrMM8HF8th04jDlbqsinMc6dwf-vSUGGLriDuUyyS9BZuei4i8B5uzk-n4i2FkdCxcANbn7Lnwad3lNLuVIxG0FgetnRuz021TkC24d2U2TQx5xe-w6BbcqbKlWn1Ti8VP89PRA9BtzcyxlMtBVUaD-PsvpI__W_WHcL8BsGxsNB7Bhs4ew97UMGCvDtjpOqGrOGB7bLrmxl49AT1mh93NhyxPGeJPFMmL5Xl-XRWsJsvKSvY1Y3Q4pA1pzOwn1WOEIcxmE32VU8oL8amwqeGGLUjrGCf_7CnMjj6cHk6s5qYHK_YdUVpO6nlC-bbiaRjZykYM4kTcjSMhlKt5yD07CBG7BF7AHbovSCgEHgGiIVVzsvFt6GV5pp8BSxOtoyTUIiJvQ_A4QgdEEJhqwVMU7cOw7WEZNzTodBvHQtJyCI3JpqmxgWXdwH1422ksDQXIH2THpgs7yaYD15LYdb40HWh0OhHKs8Ng1Yd3N_xNNlGlkHHhk5m5RNSGymjEplco6WcbPWhXHBG604fXrYtKDBe0B6QynVeFxOW5GwSI-bCoO8Z3u6KOAspIoS_7nTP_tcbP_0X4Bdylopvjzi-hV15X-hWCujLaxeXMx0-7zcj9AQ9pShQ
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED-6dLCWse9u2RcajMJG7diR_JG3hW4lFFby0ED3JGRbStemdqhjRvbX786ynXWMjbEX-8F3QtKdTj9Zup8A3sYeTaMmdrwg447gWeYoXyjHKMp6DEzEQ0pw_nwSTmbi-Cw424KPbS4MHau8QFw01_Ry54V7sRw0nThYq8uqPMeRzqNBRE-JIbaOuAO5zMwt2A4DROQ92J6dTMdfLCOj7-ACsD5nz0VE6y6_2a0cirgt0W3LuTE73bYV2YW7V3bTxJJX_A6L7sKdKl-q9Te1WPw0Px3dB922zB5LuXSrVeKm338hffzfpj-Aew2AZWOr8RC2dP4I9qeWAXt9wE43CV3lAdtn0w039vox6DE77G4-ZIVhiD9RpCiX58V1VbKaLCtfsa85o8MhbUhjdj-pHiMMYTab6KuCUl6IT4VNLTdsSVrHOPnnT2B29On0cOI0Nz04aeSLleObMBQq8hQ3o8RTHmIQP-FBmgihAs1HPPTiEWKXOIy5T_cFCYXAI0Y0pGpONr4HvbzI9TNgJtM6yUZaJORtCB6H6IAIAo0W3KBoHwathWXa0KDTbRwLScshLEw2XY0dLOsO7sO7TmNpKUD-IDu2JuwkGwNuJNF0kbQGtDqdCOXZYbDqw4cb_iabqFLKtIyomLlE1IbKWIhHr5Gkn230oF1xROh-H960LioxXNAekMp1UZUSl-dBHCPmw6o-tb7bVXUYU0YKfXnfOfNfW_z8X4RfwA5V3R53fgm91XWlXyGoWyWvmzH7A1iYSRs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Comparison+of+the+Phosphorus+Content+in+Prescription+Medications+for+Hemodialysis+Patients+in+Japan&rft.jtitle=Yakugaku+zasshi&rft.au=Shimoishi%2C+Kazuki&rft.au=Anraku%2C+Makoto&rft.au=Uto%2C+Ayako&rft.au=Iohara%2C+Daisuke&rft.date=2017-07-01&rft.eissn=1347-5231&rft.volume=137&rft.issue=7&rft.spage=903&rft_id=info:doi/10.1248%2Fyakushi.17-00006&rft_id=info%3Apmid%2F28674306&rft.externalDocID=28674306
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6903&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6903&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6903&client=summon